Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What Growth Opportunities are Expected to Drive the Sugar-Based Excipients Market’s CAGR Through 2034?

The market for sugar-based excipients has been experiencing consistent growth in recent years, with its size forecasted to increase from $1.43 billion in 2024 to $1.50 billion in 2025. This growth equals a compound annual growth rate (CAGR) of 4.5%. Factors contributing to this growth during the historic period include the expansion of the pharmaceutical industry, increased demand for formulations suited to pediatric and geriatric populations, a rising number of chronic diseases, increased use of nutraceuticals, and the need for improved solubility and stability.

The market for sugar-based excipients is anticipated to witness consistent expansion in the upcoming years, reaching $1.76 billion in 2029 with a 4.1% compound annual growth rate (CAGR). This surge during the projected period is largely due to the increased requirement for oral solid dosage forms, the expansion of nutraceutical industries, greater use of sugar-based excipients in pediatric and geriatric mixtures, growing prevalence of chronic health conditions and the linked drug demand, along with an increasing elderly population. Notable trends expected during this period encompass improved functional excipients, a move toward non-GMO and natural components, technological advancements, developments in orally disintegrating tablets (ODTs), and the incorporation of sugar alcohols.

Which Macro and Microeconomic Factors Are Accelerating the Growth of the Sugar-Based Excipients Market?

The surge in the pharmaceutical industry’s recognition is predicted to fuel the expansion of the sugar-based excipients sector moving forward. The focus of this industry is to improve health outcomes through the research, development, manufacture, and promotion of various medicines. With the escalating need for pioneering treatments, progress in drug development technologies and growing worldwide healthcare requirements, the demand for pharmaceuticals is on the rise. In pharmaceuticals, sugar-based excipients play the role of fillers, binders and stabilizers, thus improving the taste, formulation and bioavailability of drugs. For instance, the European Federation of Pharmaceutical Industries and Associations (EFPIA), a trade association based in Belgium, reported in June 2023 that total pharmaceutical production in Europe reached $384,200 million (€340,000 million) in 2022, a significant growth of around 4.95% from 366,267 million (€323,950 million) in 2021. Hence, the escalating recognition of the pharmaceutical industry is propelling the sugar-based excipients market growth.

Request Your Free Sugar-Based Excipients Market Report Sample Now!

https://www.thebusinessresearchcompany.com/sample.aspx?id=21291&type=smp

What Are the Leading Industry Players Dominating the Sugar-Based Excipients Market?

Major companies operating in the sugar-based excipients market are Cargill Incorporated, Archer Daniels Midland Company, Associated British Foods PLC, DuPont de Nemours Inc., IFF Pharmaceuticals Solutions, Ingredion Incorporated, Tereos S.A., Roquette Frères S.A., IMCD N.V., The Lubrizol Corporation, Ashland Global Holdings Inc., Tate & Lyle PLC, Colorcon Inc., DFE Pharma, Emilio Castelli S.R.L., Pfanstiehl Inc., Meggle AG, Scope Ingredients Pvt. Ltd., Citron Scientific, MB Sugars & Pharmaceuticals

What Are the Latest Trends Leading to Disruption in the Sugar-Based Excipients Market?

The primary players in the sugar-based excipients market are emphasizing on novel proposals, such as the advanced mannitol products, to boost drug stability, improve solubility, and idealize the overall performance of pharmaceutical applications. These advanced formulations of mannitol are specifically contrived to enhance drug stability, increase solubility, and streamline tablet compression for superior pharmaceutical function. For example, Roquette Freres, a company based in France, in October 2022, introduced its two mannitol-based excipients, PEARLITOL CR-H and PEARLITOL 200 GT, intended for direct compression in pharmaceutical compounds. These innovative creations improved the processability of tablets, managed release, and accelerated the manufacturing process, presenting fresh solutions for addressing challenges in drug formulation.

Pre-order Your Report for Quick and Easy Delivery!

https://www.thebusinessresearchcompany.com/report/sugar-based-excipients-global-market-report

What Are the Strategic Segments Comprising the Sugar-Based Excipients Market and Their Growth Contributions?

The sugar-based excipients market covered in this report is segmented –

1) By Product: Actual Sugar, Artificial Sweeteners, Sugar Alcohol

2) By Dosage Form: Liquid Dosage Forms, Semi-Solid Dosage Forms, Solid Dosage Forms

3) By Application: Diluents, Fillers, Tonicity Agents, Flavoring Agents

4) By End User: Pharmaceutical Industry, Food And Beverage Industry, Cosmetics And Personal Care Industry

Subsegments:

1) Actual Sugar: Sucrose, Lactose, Dextrose, Fructose, Other Actual Sugars

2) Artificial Sweeteners: Aspartame, Saccharin, Sucralose, Acesulfame K, Other Artificial Sweeteners

3) Sugar Alcohol: Mannitol, Sorbitol, Xylitol, Maltitol, Other Sugar Alcohols

Which Regions Are Significant to the Growth of the Sugar-Based Excipients Market?

North America was the largest region in the sugar-based excipients market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sugar-based excipients market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

How Can We Define the Sugar-Based Excipients Market and Its Key Components?

Sugar-based excipients refer to a category of pharmaceutical excipients derived from sugars and their derivatives, such as sucrose, lactose, glucose, sorbitol, and mannitol. These excipients are used in drug formulations to perform various roles, enhancing the physical and chemical properties of medications and improving patient compliance.

Browse Through More Similar Reports By The Business Research Company:

Insulin Biosimilars Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/insulin-biosimilars-global-market-report

Insulin Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/insulin-drugs-global-market-report

Non-injectable Insulin Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/non-injectable-insulin-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: